JP2003521439A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003521439A5 JP2003521439A5 JP2000534230A JP2000534230A JP2003521439A5 JP 2003521439 A5 JP2003521439 A5 JP 2003521439A5 JP 2000534230 A JP2000534230 A JP 2000534230A JP 2000534230 A JP2000534230 A JP 2000534230A JP 2003521439 A5 JP2003521439 A5 JP 2003521439A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- monocytes
- factor
- functional
- functional analogue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98103859.9 | 1998-03-05 | ||
| EP98103859 | 1998-07-15 | ||
| PCT/EP1999/001440 WO1999044629A2 (de) | 1998-03-05 | 1999-03-05 | Verwendung von cd137 zur förderung der proliferation peripherer monocyten |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003521439A JP2003521439A (ja) | 2003-07-15 |
| JP2003521439A5 true JP2003521439A5 (https=) | 2006-04-20 |
Family
ID=8231533
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000534230A Pending JP2003521439A (ja) | 1998-03-05 | 1999-03-05 | 末梢単球の増殖を促進するためのｃｄ１３７の使用 |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US6627200B1 (https=) |
| EP (1) | EP1059931B1 (https=) |
| JP (1) | JP2003521439A (https=) |
| KR (1) | KR20010041624A (https=) |
| AT (1) | ATE228371T1 (https=) |
| AU (1) | AU747063B2 (https=) |
| BR (1) | BR9908518A (https=) |
| CA (1) | CA2322684A1 (https=) |
| CZ (1) | CZ20003238A3 (https=) |
| DE (1) | DE59903541D1 (https=) |
| DK (1) | DK1059931T3 (https=) |
| EE (1) | EE200000510A (https=) |
| ES (1) | ES2188140T3 (https=) |
| HU (1) | HUP0102046A3 (https=) |
| IS (1) | IS1986B (https=) |
| NO (1) | NO20004393L (https=) |
| NZ (1) | NZ506695A (https=) |
| PL (1) | PL343427A1 (https=) |
| PT (1) | PT1059931E (https=) |
| SI (1) | SI1059931T1 (https=) |
| WO (1) | WO1999044629A2 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050232896A1 (en) * | 2001-10-04 | 2005-10-20 | Herbert Schwarz | Cd137 as a proliferation factor for hematopoietic stem cells |
| JP2006508056A (ja) | 2002-08-28 | 2006-03-09 | イミュネックス・コーポレーション | 心臓血管疾患を治療するための組成物および方法 |
| EP1575672A2 (en) * | 2002-12-16 | 2005-09-21 | Herbert Schwarz | Use of cd137 antagonists for the treatment of tumors |
| US7288638B2 (en) | 2003-10-10 | 2007-10-30 | Bristol-Myers Squibb Company | Fully human antibodies against human 4-1BB |
| JP5861191B2 (ja) * | 2010-09-30 | 2016-02-16 | 国立大学法人 熊本大学 | ミエロイド系血液細胞の製造方法 |
| EP2981334A4 (en) * | 2013-04-03 | 2016-11-23 | Univ California | COMPOSITIONS AND METHODS FOR INHIBITING VIRAL ACTIVITY |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH03145499A (ja) * | 1989-10-31 | 1991-06-20 | Nippon Kosei Butsushitsu Gakujiyutsu Kiyougikai | ヒト単球成長因子 |
| DE4222980A1 (de) | 1992-07-13 | 1994-01-20 | Cassella Ag | Verwendung von 2-(N-(2-Aminoethyl)amino)-essigsäure-derivaten |
| US5674704A (en) * | 1993-05-07 | 1997-10-07 | Immunex Corporation | Cytokine designated 4-IBB ligand |
| JPH09503911A (ja) * | 1993-09-16 | 1997-04-22 | インディアナ・ユニバーシティー・ファウンデーション | ヒトｈ４−１ｂｂ受容体 |
| CA2108401A1 (en) * | 1993-09-27 | 1995-03-28 | The Regents Of The University Of California | Receptor induced by lymphocyte activation in imflammatory response |
-
1999
- 1999-03-05 HU HU0102046A patent/HUP0102046A3/hu unknown
- 1999-03-05 KR KR1020007009823A patent/KR20010041624A/ko not_active Ceased
- 1999-03-05 US US09/623,545 patent/US6627200B1/en not_active Expired - Fee Related
- 1999-03-05 NZ NZ506695A patent/NZ506695A/en unknown
- 1999-03-05 CA CA002322684A patent/CA2322684A1/en not_active Abandoned
- 1999-03-05 AU AU29324/99A patent/AU747063B2/en not_active Ceased
- 1999-03-05 WO PCT/EP1999/001440 patent/WO1999044629A2/de not_active Ceased
- 1999-03-05 DK DK99910331T patent/DK1059931T3/da active
- 1999-03-05 EP EP99910331A patent/EP1059931B1/de not_active Expired - Lifetime
- 1999-03-05 ES ES99910331T patent/ES2188140T3/es not_active Expired - Lifetime
- 1999-03-05 JP JP2000534230A patent/JP2003521439A/ja active Pending
- 1999-03-05 EE EEP200000510A patent/EE200000510A/xx unknown
- 1999-03-05 PL PL99343427A patent/PL343427A1/xx not_active Application Discontinuation
- 1999-03-05 PT PT99910331T patent/PT1059931E/pt unknown
- 1999-03-05 AT AT99910331T patent/ATE228371T1/de not_active IP Right Cessation
- 1999-03-05 SI SI9930165T patent/SI1059931T1/xx unknown
- 1999-03-05 DE DE59903541T patent/DE59903541D1/de not_active Expired - Fee Related
- 1999-03-05 BR BR9908518-6A patent/BR9908518A/pt not_active IP Right Cessation
- 1999-03-05 CZ CZ20003238A patent/CZ20003238A3/cs unknown
-
2000
- 2000-08-30 IS IS5613A patent/IS1986B/is unknown
- 2000-09-04 NO NO20004393A patent/NO20004393L/no unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0495639A1 (en) | Use of interleukin-10 in adoptive immunotherapy of cancer | |
| AU7746698A (en) | Genetically modified cells and their use in the prophylaxis or therapy of disorders | |
| CN114958771B (zh) | 一种ipsc-car-nk细胞的制备方法 | |
| CN110903348B (zh) | 一种促进伤口愈合的小肽及其应用 | |
| CA2121487A1 (en) | Combined cellular and immunosuppresive therapies | |
| CN104789595A (zh) | 嵌合抗原受体双阴性t细胞的构建方法 | |
| CN113166724A (zh) | 从iPSC及其衍生物制备用于任何临床用途的外泌体的方法 | |
| CN102027104A (zh) | 含有细胞因子诱导杀伤细胞的细胞群的制造方法 | |
| JP2003521439A5 (https=) | ||
| CN115210363B (zh) | 用于增强干细胞功能的组合物 | |
| Brack et al. | Hematopoietic growth factors: interactions and regulation of production | |
| JP2021512164A5 (https=) | ||
| KR101656511B1 (ko) | 육모 및 탈모방지능이 개선된 지방줄기세포 배양액 및 그의 제조방법 | |
| CN113699117B (zh) | 经基因改造的少突胶质祖细胞在多发性硬化症中的应用 | |
| Lam et al. | Targeting mesenchymal stem cell therapy for severe pneumonia patients | |
| Morita et al. | Differentiation of a human eosinophilic leukemia cell line (EoL-1) by a human T-cell leukemia cell line (HIL-3)-derived factor | |
| WO2018009506A1 (en) | Erythroid-specific promoter and method of use thereof | |
| Gottipati et al. | Delayed administration of interleukin-4 coacervate alleviates the neurotoxic phenotype of astrocytes and promotes functional recovery after a contusion spinal cord injury | |
| JP2015521476A (ja) | 細胞の免疫調節効果の改良 | |
| WO2016071911A1 (en) | Treatment of cns inflammatory disorders | |
| Platter et al. | Lymphokines and monokines in the clinic | |
| JP2024154083A (ja) | ＳＡＲＳ－ＣｏＶ－２特異的細胞傷害性Ｔリンパ球のＴ細胞受容体又はその機能的断片 | |
| JP7412576B2 (ja) | 腎がんの相乗的治療におけるペグインターフェロンおよびプロトオンコジーン産物標的阻害剤の適用 | |
| JP2005102656A (ja) | 細胞培養器具およびそれを用いた細胞製剤の製造方法 | |
| WO1997031532A1 (en) | Antisense interleukin 10 and methods of use |